Skip to content

Opening book details…

About this Economics, Econometrics and Finance article

Pcn25 Cost-effectiveness Analysis Of Erlotinib Versus Docetaxel As A Second- Or Third-line Treatment Of Non-small Cell Lung Cancer In Korea by Kim, YG; Lee, EK is a Economics, Econometrics and Finance article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.

Author
Kim, YG; Lee, EK
Publisher
John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)
Published
2010
Language
EN
Field
Economics, Econometrics and Finance (Social Sciences)

More by Kim, YG; Lee, EK

Browse all works by Kim, YG; Lee, EK